CA2022682A1 - Cycloalkylene azoles, procede de production et utilisation et preparations pharmaceutiques ainsi obtenues - Google Patents

Cycloalkylene azoles, procede de production et utilisation et preparations pharmaceutiques ainsi obtenues

Info

Publication number
CA2022682A1
CA2022682A1 CA2022682A CA2022682A CA2022682A1 CA 2022682 A1 CA2022682 A1 CA 2022682A1 CA 2022682 A CA2022682 A CA 2022682A CA 2022682 A CA2022682 A CA 2022682A CA 2022682 A1 CA2022682 A1 CA 2022682A1
Authority
CA
Canada
Prior art keywords
well
processes
production
methods
pharmaceutical preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2022682A
Other languages
English (en)
Other versions
CA2022682C (fr
Inventor
Rolf Bohlmann
Peter Strehlke
David Henderson
Martin Schneider
Yukishige Nishino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2022682A1 publication Critical patent/CA2022682A1/fr
Application granted granted Critical
Publication of CA2022682C publication Critical patent/CA2022682C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002022682A 1989-08-04 1990-08-03 Cycloalkylene azoles, procede de production et utilisation et preparations pharmaceutiques ainsi obtenues Expired - Fee Related CA2022682C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3926365.7 1989-08-04
DE3926365A DE3926365A1 (de) 1989-08-04 1989-08-04 Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
CA2022682A1 true CA2022682A1 (fr) 1991-02-05
CA2022682C CA2022682C (fr) 1997-01-21

Family

ID=6386820

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022682A Expired - Fee Related CA2022682C (fr) 1989-08-04 1990-08-03 Cycloalkylene azoles, procede de production et utilisation et preparations pharmaceutiques ainsi obtenues

Country Status (19)

Country Link
US (3) US5135937A (fr)
EP (1) EP0411735B1 (fr)
JP (1) JP3207417B2 (fr)
CN (1) CN1024345C (fr)
AT (1) ATE122662T1 (fr)
AU (1) AU634266B2 (fr)
CA (1) CA2022682C (fr)
DD (1) DD296917A5 (fr)
DE (2) DE3926365A1 (fr)
DK (1) DK0411735T3 (fr)
ES (1) ES2074530T3 (fr)
FI (1) FI920425A7 (fr)
HU (2) HU217126B (fr)
IE (1) IE902843A1 (fr)
IL (1) IL95279A (fr)
NO (1) NO301115B1 (fr)
PT (1) PT94884B (fr)
WO (1) WO1991001975A1 (fr)
ZA (1) ZA906150B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
TW224461B (fr) * 1990-09-18 1994-06-01 Ciba Geigy Ag
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
BR0013272B1 (pt) 1999-08-13 2013-10-15 Uso de um inibidor de aromatase esteroidal
CN101253160A (zh) * 2005-07-06 2008-08-27 西科尔公司 制备来曲唑的改进方法
CN100425621C (zh) * 2006-07-06 2008-10-15 云南大学 甾体咪唑盐类化合物及其制备方法
CN116925001B (zh) * 2023-07-26 2025-09-30 陕西师范大学 一种抗乳腺癌药物来曲唑类似物的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles

Also Published As

Publication number Publication date
ZA906150B (en) 1991-05-29
JPH05501104A (ja) 1993-03-04
FI920425A0 (fi) 1992-01-30
NO301115B1 (no) 1997-09-15
CN1049157A (zh) 1991-02-13
US5135937A (en) 1992-08-04
ES2074530T3 (es) 1995-09-16
IL95279A0 (en) 1991-06-30
EP0411735A1 (fr) 1991-02-06
CN1024345C (zh) 1994-04-27
WO1991001975A1 (fr) 1991-02-21
AU6019490A (en) 1991-02-07
JP3207417B2 (ja) 2001-09-10
IE902843A1 (en) 1991-02-27
US5280035A (en) 1994-01-18
PT94884A (pt) 1991-04-18
EP0411735B1 (fr) 1995-05-17
DE3926365A1 (de) 1991-02-07
CA2022682C (fr) 1997-01-21
HUT59911A (en) 1992-07-28
US5411982A (en) 1995-05-02
FI920425A7 (fi) 1992-01-30
DE59009084D1 (de) 1995-06-22
NO920432D0 (no) 1992-02-03
PT94884B (pt) 1997-04-30
NO920432L (no) 1992-02-03
IL95279A (en) 1995-03-30
DK0411735T3 (da) 1995-10-16
DD296917A5 (de) 1991-12-19
HU217126B (hu) 1999-11-29
ATE122662T1 (de) 1995-06-15
HU9200324D0 (en) 1992-04-28
AU634266B2 (en) 1993-02-18

Similar Documents

Publication Publication Date Title
CA2067221A1 (fr) Derive pyrimidine a cycles condenses, procede pour sa preparation et preparation pharmaceutique en contenant comme ingredient actif
CA2014545A1 (fr) Derives d'acide biliaire; methode de preparation desdits derives et compositions pharmaceutiques utilisant ces derives
DE3479119D1 (en) Novel carbostyril derivative and process for preparing same
IE880213L (en) Purines and imidazoles.
CA2022682A1 (fr) Cycloalkylene azoles, procede de production et utilisation et preparations pharmaceutiques ainsi obtenues
CA2115536A1 (fr) Derives heterocycliquement substitues de phenyl-cyclohexane-acide carboxylique
CA2024849A1 (fr) 4-hydroxytetrahydopyran-2-ones et les derives correspondants de l'acide dihydroxycarboxylique, sels et esters, procede de preparation, utilisation en tant que composes pharmaceutiques, et preparations pharmaceutiques et precurseurs
CA2002834A1 (fr) Xanthines cycloalkyles
CA2210492A1 (fr) Derives de l'acide neuraminique, leur preparation et leur utilisation medicale
CA2013518A1 (fr) Derives de thieno-triazolo-diazepine, procede de preparation et composes therapeutiques les contenant
EP1069125A3 (fr) Dérivés carbamates de 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones et d'analogues de l'acide 1-amino-1-cyclopropane carboxylique, procédé pour leur préparation et leur application comme médicaments
CA2032254A1 (fr) Derives de glycerol, mode de preparation et compositions therapeutiques en contenant
EP0354568A3 (fr) Dérivés du catéchol
ES8507110A1 (es) Procedimiento para la preparacion de derivados del acido indolacetico
EP0066909A3 (fr) Dérivés d'imidazole, leurs compositions pharmaceutiques et procédés pour leur préparation
EP0565146A3 (fr) Usage d'un ester thioique pour la préparation de compositions pharmaceutiques de traitement l'ischémie et de syndromes de reperfusion
IE812944L (en) Pyrazoline derivatives
FR2457867A1 (fr) Nouveaux derives d'hydroxyamino-eburnane : leur procede de preparation, intermediaires utilises et utilisation comme medicament et comme intermediaire
EP0218953A3 (fr) Dérivés de l'acide 19,20-bis-nor-prostanoique à activité anti-ulcéreuse et anorétique, leur procédé de préparation et compositions pharmaceutiques
CA2096515A1 (fr) Les benzo[b]thiophen-3-yl-piperazines, leur procede de preparation et leur utilisation comme medicaments
CA2045761A1 (fr) Monosulfate ou disulfate ws7622a; methode de preparation et utilisation
JPS5610188A (en) Xanthine derivative and its preparation
CA2032224A1 (fr) Derives du 3-(n-methyl-n-alkyl)-amino-2- methoxymethylenepropan-1-ol, un procede pour les preparer et les compositions pharmaceutiques les renfermant
EP0302633A3 (fr) Composés bêta-lactame, procédé pour leur préparation, intermédiaires pour leur synthèse et leurs compositions pharmaceutiques les contenant pour la thérapie des maladies infectieuses bactériennes
CA2025663A1 (fr) Derives d'indole

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed